← Back to Search

Personalized Screening Plans for Colorectal Cancer

Phase 3

Waitlist Available

Research Sponsored by Sidney Kimmel Cancer Center at Thomas Jefferson University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

No family history of colorectal cancer (CRC) diagnosed before the age of 60

No personal history of colorectal neoplasia (cancer or polyps) or inflammatory bowel disease

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 5 years

Awards & highlights

Study Summary

This trial is studying whether a personalized screening plan is more effective than usual care in increasing colorectal cancer screening in healthy participants.

Who is the study for?

This trial is for healthy individuals who haven't been screened for colorectal cancer as recommended. They should not have a personal or early family history of colorectal cancer, no prior inflammatory bowel disease, and must be part of the Christiana Care Health System in Delaware with up-to-date contact information.Check my eligibility

What is being tested?

The study is testing if personalized screening plans are more effective than standard care at increasing regular colorectal cancer screenings among healthy people. It's a phase III trial where participants are randomly assigned to receive either the new approach or usual care.See study design

What are the potential side effects?

Since this trial involves screening strategies rather than medications, there aren't direct side effects like those associated with drugs. However, any medical procedure can carry risks such as discomfort or stress.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

No one in my family had colorectal cancer before 60.

Select...

I have never had colorectal cancer, polyps, or inflammatory bowel disease.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 5 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 5 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Screening utilization over the 6-month observation period

Secondary outcome measures

Identification of predictors of CRC screening use and screening preference

Number and length of contacts with each participant and the type of communication during those contacts

Perceived salience and coherence and self-efficacy related to colorectal cancer (CRC) screening

+1 more

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Sidney Kimmel Cancer Center at Thomas Jefferson UniversityLead Sponsor

162 Previous Clinical Trials

10,011 Total Patients Enrolled

National Cancer Institute (NCI)NIH

13,658 Previous Clinical Trials

40,923,589 Total Patients Enrolled

Ronald Myers, PhDStudy ChairJefferson Medical College of Thomas Jefferson University

2 Previous Clinical Trials

3,396 Total Patients Enrolled

Media Library

Personalized Screening Plans Clinical Trial Eligibility Overview. Trial Name: NCT00617071 — Phase 3

Colorectal Cancer Research Study Groups:

Colorectal Cancer Clinical Trial 2023: Personalized Screening Plans Highlights & Side Effects. Trial Name: NCT00617071 — Phase 3

Personalized Screening Plans 2023 Treatment Timeline for Medical Study. Trial Name: NCT00617071 — Phase 3

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are elderly citizens being recruited for this trial?

"This particular clinical trial is only for patients aged 50 to 74. If a person does not meet this age requirement, they can look into the 39 other trials for people under 18 or the 1092 trials for patients over 65."

Answered by AI